Annales pharmaceutiques francaises
Therapeutic Potential of a Polyherbal Extract Against COVID-19 and Associated Inflammation and Mucormycosis: In Vitro Characterization and In Vivo Validation in a Human Coronavirus 229E-Infected Mouse Model.
Shrikant S Magdum, John I Disouza, Arehalli S Manjappa, Sunil T Galatage
Published: 202610.1016/j.pharma.2026.01.004
Abstract
The rise of viral infections has been accompanied by an increased incidence of secondary opportunistic infections, such as mucormycosis, highlighting the urgent need for broad-spectrum therapeutics capable of targeting multiple pathological pathways.…
Preview only. Read the full abstract at the source